Cencora Stock
Cencora, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- United States
- CEO
- Robert Mauch
- Employees
- 49,000
- Market cap
- $65.1 B
- IPO
- 04/04/1995
Cencora, Inc. (COR) operates in the Healthcare / Medical - Distribution sector and specializes in the procurement and distribution of pharmaceuticals. Headquartered in Conshohocken, the company covers a broad spectrum ranging from generic medicines and vaccines to specialty logistics solutions for biopharmaceuticals.…
AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.
Cencora stock: price history
1D
-0.1%
1W
+5.3%
1M
+7.0%
6M
+4.1%
YTD
+0.9%
1Y
+6.7%
2Y
+44.1%
5Y
+184.4%
10Y
+320.4%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~63% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Cencora stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Cencora is a global healthcare player that primarily focuses on the procurement and distribution of pharmaceutical products. Beyond high-volume trading of medicines, vaccines, and blood derivatives, the company offers specialized services including software solutions for supply chain management, data analytics for biopharma manufacturers, and support for clinical trials and commercialization. The business model further encompasses logistics for the international market and serves not only human healthcare but also the animal health market through the provision of products and diagnostics.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- Medium
- Customer concentration
- Unknown
Ask the agents about Cencora
Analyst assessment of Cencora
PRICE TARGET LOW
US$330.00
CONSENSUS
US$353.86
MEDIAN
US$350.00
PRICE TARGET HIGH
US$400.00
0
STRONG BUY
33
BUY
12
HOLD
1
SELL
0
STRONG SELL
46
TOTAL · Buy
As of: 07/10/2026
Cencora stock metrics
P/E
25.22
P/B
21.58
EV/EBITDA
14.36
RETURN ON EQUITY
25.0%
NET MARGIN
0.9%
DEBT/EQUITY
3.84
DIVIDEND YIELD
0.7%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.5%
FLOAT SHARES
180,249,615
AVG. DAILY VOLUME (30D)
1,272,300
Insider transactions (SEC)
Krikorian Lazarus
SANCHEZ ROBERT E
GREENBERG LON R
Krikorian Lazarus
Campbell Elizabeth S
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.1%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Cencora stock
What does Cencora do?
Cencora, Inc. is a company in the Healthcare sector, Medical - Distribution industry, headquartered in United States.
The CEO is Robert Mauch, the company employs around 49,000 people.
The IPO was on 04/04/1995; the stock trades on NYSE under the ticker COR.
What do analysts say about Cencora stock?
46 analysts rate the stock, the consensus is Buy (as of 07/10/2026).
The average price target is US$353.86, ranging from US$330.00 to US$400.00, with a median of US$350.00.
This is an external assessment, not a statement by Market Jury.
When does Cencora report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 63% stronger than usual.
Does Cencora pay a dividend?
Yes. The last dividend was US$0.60 per share, ex-date 14/08/2026, paid on 31/08/2026.
The dividend yield is 0.7% (as of 30/06/2026).
Which stocks are comparable to Cencora?
Comparable stocks include McKesson, Cardinal Health, Henry Schein, DocMorris, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get Cencora stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cencora against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.